• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于预测发生威胁视力的糖尿病视网膜病变时间的简单风险分层方法。

A simple risk stratification for time to development of sight-threatening diabetic retinopathy.

机构信息

Gloucestershire Diabetic Retinopathy Research Group, Cheltenham General Hospital, Cheltenham, Gloucestershire, United Kingdom.

出版信息

Diabetes Care. 2013 Mar;36(3):580-5. doi: 10.2337/dc12-0625. Epub 2012 Nov 12.

DOI:10.2337/dc12-0625
PMID:23150285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3579348/
Abstract

OBJECTIVE

The American Diabetes Association and the English NHS Diabetic Eye Screening Program recommend annual screening for diabetic retinopathy (DR) with referral to ophthalmology clinics of patients with sight-threatening DR (STDR). Using only longitudinal data from retinal photographs in the population-based NHS Diabetic Eye Screening Program in Gloucestershire, we developed a simple means to estimate risk of STDR.

RESEARCH DESIGN AND METHODS

From 2005, 14,554 patients with no DR or mild nonproliferative DR only at two consecutive annual digital photographic screenings were categorized by the presence of DR in neither, one, or both eyes at each screening and were followed for a further median 2.8 years.

RESULTS

Of 7,246 with no DR at either screening, 120 progressed to STDR, equivalent to an annual rate of 0.7%. Of 1,778 with no DR in either eye at first screening and in one eye at second screening, 80 progressed to STDR, equivalent to an annual rate of 1.9% and to a hazard ratio (HR) of 2.9 (95% CI 2.2-3.8) compared with those with no DR. Of 1,159 with background DR in both eyes at both screenings, 299 progressed to STDR equivalent to an annual rate of 11% and an HR of 18.2 (14.7-22.5) compared with individuals with no DR.

CONCLUSIONS

Combining the results from 2 consecutive years of photographic screening enables estimation of the risk of future development of STDR. In countries with systematic screening programs, these results could inform decisions about screening frequency.

摘要

目的

美国糖尿病协会和英国国民保健署糖尿病眼病筛查计划建议对糖尿病视网膜病变(DR)进行年度筛查,并将有威胁视力的 DR(STDR)患者转诊至眼科诊所。我们仅使用基于人群的格洛斯特郡国民保健署糖尿病眼病筛查计划中的视网膜照片的纵向数据,开发了一种简单的方法来估计 STDR 的风险。

研究设计和方法

自 2005 年以来,在连续两次数字摄影筛查中均无 DR 或仅轻度非增殖性 DR 的 14554 例患者,根据两次筛查中每只眼睛均无、一只或两只眼睛的 DR 存在情况进行分类,并进一步随访中位数为 2.8 年。

结果

在两次筛查中均无 DR 的 7246 例患者中,有 120 例进展为 STDR,年发生率为 0.7%。在首次筛查中每只眼睛均无 DR 而在第二次筛查中仅一只眼睛有 DR 的 1778 例患者中,有 80 例进展为 STDR,年发生率为 1.9%,与无 DR 的患者相比,风险比(HR)为 2.9(95%CI 2.2-3.8)。在两次筛查中均有背景性 DR 的 1159 例患者中,有 299 例进展为 STDR,年发生率为 11%,与无 DR 的患者相比,HR 为 18.2(14.7-22.5)。

结论

结合连续两年的摄影筛查结果,可以估计未来发展为 STDR 的风险。在有系统筛查计划的国家,这些结果可以为筛查频率的决策提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ae/3579348/df8f46fd0fe9/580fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ae/3579348/de6562a44cf6/580fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ae/3579348/df8f46fd0fe9/580fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ae/3579348/de6562a44cf6/580fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ae/3579348/df8f46fd0fe9/580fig2.jpg

相似文献

1
A simple risk stratification for time to development of sight-threatening diabetic retinopathy.一种用于预测发生威胁视力的糖尿病视网膜病变时间的简单风险分层方法。
Diabetes Care. 2013 Mar;36(3):580-5. doi: 10.2337/dc12-0625. Epub 2012 Nov 12.
2
Longitudinal Screening for Diabetic Retinopathy in a Nationwide Screening Program: Comparing Deep Learning and Human Graders.全国性筛查项目中糖尿病视网膜病变的纵向筛查:深度学习与人工分级比较。
J Diabetes Res. 2020 Dec 15;2020:8839376. doi: 10.1155/2020/8839376. eCollection 2020.
3
Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study.中国糖尿病视网膜病变的患病率及危险因素:一项基于多医院的横断面研究。
Br J Ophthalmol. 2017 Dec;101(12):1591-1595. doi: 10.1136/bjophthalmol-2017-310316. Epub 2017 Aug 30.
4
Correlation between markers of renal function and sight-threatening diabetic retinopathy in type 2 diabetes: a longitudinal study in an Indian clinic population.2型糖尿病患者肾功能指标与威胁视力的糖尿病视网膜病变之间的相关性:一项针对印度门诊患者的纵向研究
BMJ Open Diabetes Res Care. 2020 May;8(1). doi: 10.1136/bmjdrc-2020-001325.
5
Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening.开发用于优化糖尿病视网膜病变筛查间隔的成本效益模型。
Health Technol Assess. 2015 Sep;19(74):1-116. doi: 10.3310/hta19740.
6
Ethnic disparities in progression rates for sight-threatening diabetic retinopathy in diabetic eye screening: a population-based retrospective cohort study.在糖尿病眼病筛查中,威胁视力的糖尿病视网膜病变进展率的种族差异:一项基于人群的回顾性队列研究。
BMJ Open Diabetes Res Care. 2023 Nov;11(6). doi: 10.1136/bmjdrc-2023-003683.
7
Profile of sight-threatening diabetic retinopathy and its awareness among patients with diabetes mellitus attending a tertiary care center in Kashmir, India.印度克什米尔一家三级医疗中心糖尿病患者中威胁视力的糖尿病视网膜病变概况及其知晓情况。
Indian J Ophthalmol. 2021 Nov;69(11):3123-3130. doi: 10.4103/ijo.IJO_831_21.
8
A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy.意大利东北部长达十年的糖尿病视网膜病变远程医疗筛查项目。
J Diabetes Complications. 2017 Aug;31(8):1348-1353. doi: 10.1016/j.jdiacomp.2017.04.010. Epub 2017 Apr 13.
9
Risk factors for diabetic retinopathy, diabetic macular edema, and sight-threatening diabetic retinopathy.糖尿病视网膜病变、糖尿病黄斑水肿和威胁视力的糖尿病视网膜病变的危险因素。
Asia Pac J Ophthalmol (Phila). 2024 May-Jun;13(3):100067. doi: 10.1016/j.apjo.2024.100067. Epub 2024 May 13.
10
Accuracy of the smartphone-based nonmydriatic retinal camera in the detection of sight-threatening diabetic retinopathy.基于智能手机的免散瞳视网膜相机检测威胁视力的糖尿病视网膜病变的准确性。
Indian J Ophthalmol. 2020 Feb;68(Suppl 1):S42-S46. doi: 10.4103/ijo.IJO_1937_19.

引用本文的文献

1
Diabetic retinopathy-recommendations for screening and treatment.糖尿病视网膜病变——筛查与治疗建议
Wien Med Wochenschr. 2025 Jun;175(9-10):253-263. doi: 10.1007/s10354-025-01088-6. Epub 2025 May 9.
2
Experience of linking to the NHS diabetic eye screening programme records in the ASCEND-eye randomized trial and recommendations for improvement.在ASCEND-eye随机试验中链接到英国国家医疗服务体系糖尿病眼部筛查计划记录的经验及改进建议。
Contemp Clin Trials Commun. 2025 Mar 28;45:101474. doi: 10.1016/j.conctc.2025.101474. eCollection 2025 Jun.
3
A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk.

本文引用的文献

1
Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis.威尔士糖尿病视网膜病变筛查服务就诊的 2 型糖尿病患者中糖尿病视网膜病变的发生率:回顾性分析。
BMJ. 2012 Feb 22;344:e874. doi: 10.1136/bmj.e874.
2
Individualized optimization of the screening interval for diabetic retinopathy: a new model.糖尿病视网膜病变筛查间隔的个体化优化:一种新模型。
Acta Ophthalmol. 2012 Mar;90(2):109-14. doi: 10.1111/j.1755-3768.2010.01882.x. Epub 2010 Apr 6.
3
Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis.
一种基于评分的简单策略,以提高英国两年一次的糖尿病眼部筛查方案在被视为低风险人群中的公平性。
Diabetologia. 2025 Jun;68(6):1157-1168. doi: 10.1007/s00125-025-06379-6. Epub 2025 Mar 12.
4
To Determine the Risk-Based Screening Interval for Diabetic Retinopathy: Development and Validation of Risk Algorithm from a Retrospective Cohort Study.确定糖尿病视网膜病变基于风险的筛查间隔:一项回顾性队列研究中风险算法的开发与验证
Diabetes Metab J. 2025 Mar;49(2):286-297. doi: 10.4093/dmj.2024.0142. Epub 2024 Oct 31.
5
Predicting 1, 2 and 3 year emergent referable diabetic retinopathy and maculopathy using deep learning.使用深度学习预测1年、2年和3年新发可转诊性糖尿病视网膜病变和黄斑病变
Commun Med (Lond). 2024 Aug 21;4(1):167. doi: 10.1038/s43856-024-00590-z.
6
Comparison of diabetic retinopathy screening between hospital-based multidisciplinary and general practice-based settings: insights from a regional study in Italy.基于医院的多学科与基于全科医疗的糖尿病视网膜病变筛查比较:来自意大利一项区域研究的见解
Acta Diabetol. 2025 Feb;62(2):263-269. doi: 10.1007/s00592-024-02354-6. Epub 2024 Aug 19.
7
Design, recruitment and baseline characteristics of the LENS trial.LENS 试验的设计、招募和基线特征。
Diabet Med. 2024 Sep;41(9):e15310. doi: 10.1111/dme.15310. Epub 2024 Feb 22.
8
Urinary and circulatory netrin-1 as biomarker in diabetes and its related complications: a systematic review and meta-analysis.尿和循环 netrin-1 作为糖尿病及其相关并发症的生物标志物:系统评价和荟萃分析。
Endocrine. 2024 May;84(2):328-344. doi: 10.1007/s12020-023-03598-y. Epub 2023 Nov 23.
9
Ethnic disparities in progression rates for sight-threatening diabetic retinopathy in diabetic eye screening: a population-based retrospective cohort study.在糖尿病眼病筛查中,威胁视力的糖尿病视网膜病变进展率的种族差异:一项基于人群的回顾性队列研究。
BMJ Open Diabetes Res Care. 2023 Nov;11(6). doi: 10.1136/bmjdrc-2023-003683.
10
Two-year recall for people with no diabetic retinopathy: a multi-ethnic population-based retrospective cohort study using real-world data to quantify the effect.两年随访无糖尿病视网膜病变患者:一项基于真实世界数据的多民族人群回顾性队列研究,用于量化其影响。
Br J Ophthalmol. 2023 Nov 22;107(12):1839-1845. doi: 10.1136/bjo-2023-324097.
不同时期糖尿病视网膜病变进展的速率:系统评价和荟萃分析。
Diabetes Care. 2009 Dec;32(12):2307-13. doi: 10.2337/dc09-0615.
4
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes.威斯康星糖尿病视网膜病变流行病学研究:XXII 1型糖尿病患者视网膜病变的25年进展情况
Ophthalmology. 2008 Nov;115(11):1859-68. doi: 10.1016/j.ophtha.2008.08.023.
5
Diabetic retinopathy and socioeconomic deprivation in Gloucestershire.格洛斯特郡的糖尿病视网膜病变与社会经济剥夺
J Med Screen. 2008;15(3):118-21. doi: 10.1258/jms.2008.008013.
6
The English national screening programme for sight-threatening diabetic retinopathy.英国威胁视力的糖尿病视网膜病变国家筛查计划。
J Med Screen. 2008;15(1):1-4. doi: 10.1258/jms.2008.008015.
7
Screening compliance and visual outcome in diabetes.糖尿病患者的筛查依从性及视力预后
Acta Ophthalmol Scand. 2005 Dec;83(6):687-90. doi: 10.1111/j.1600-0420.2005.00541.x.
8
The prevalence of diabetic retinopathy among adults in the United States.美国成年人中糖尿病视网膜病变的患病率。
Arch Ophthalmol. 2004 Apr;122(4):552-63. doi: 10.1001/archopht.122.4.552.
9
Grading and disease management in national screening for diabetic retinopathy in England and Wales.英格兰和威尔士糖尿病视网膜病变国家筛查中的分级与疾病管理。
Diabet Med. 2003 Dec;20(12):965-71. doi: 10.1111/j.1464-5491.2003.01077.x.
10
Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme.在一项系统性筛查项目中1型糖尿病患者中威胁视力的视网膜病变发病率
Diabet Med. 2003 Sep;20(9):758-65. doi: 10.1046/j.1464-5491.2003.01035.x.